When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...

A new "trans-amplifying" mRNA vaccine delivers powerful immunity using 40 times less material and could protect against many virus strains at once. Scientists say it may pave the way for faster, ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Dr. Sarah Boyd, an infectious disease specialist with Saint Luke's Health System, told KCUR that federal cuts to mRNA research and development could cause a setback in pandemic preparedness. Last week ...

Molecular biologists have long believed that the beginning of a gene launched the process of transcription—the process by ...

A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial in patients ...